Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC YC W23 DeFi mobile wallet making yield investing accessible via account abstraction; $31.3M total ($25M Lowercarbon Series A May 2025 + 2024 seed) with auto-compounding positions competing with Coinbase Wallet for mainstream DeFi adoption.
Rainmaker is a New York City-based DeFi mobile wallet — backed by Y Combinator (W23) with $31.3 million in total funding including a $25 million Series A in May 2025 from Lowercarbon Capital and others, following a 2024 seed from Starship Ventures, Long Journey Ventures, and Day One Ventures — providing mainstream users with an account-abstraction-based mobile crypto wallet that reduces the complexity of DeFi investing to a few taps, enabling auto-compounding yield positions with performance fees (similar to Beefy.finance) and planning subscription services and integrated tax reporting. Founded in 2023 and backed by Y Combinator W23, Rainmaker targets the mass market of potential DeFi participants who are deterred by wallet complexity, gas fee management, and protocol interaction barriers.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.